Breaking

Stallion Uranium Completes First Tranche of Non-Brokered Private Placement and Announces Upsizing
West High YieldResources Ltd. Welcomes Final EAO Decision on Record Ridge Magnesium Project
Morocco, Emmerson Advance Toward US$2.2 Billion Arbitration Over Halted Potash Project
Pinnacle Silver and Gold
Osisko Metals Announces Uplisting to Toronto Stock Exchange
Providence Gold Mines Inc. Options La Dama de Oro Gold Property
ESGold Pens Colombia Tailings Project Deal as Global Reprocessing Grows
Glencore Pursues Argentina Incentives for US$13.5 Billion Copper Projects

Business
World News
Investing
Science
Search for:

Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Osisko Metals Announces Uplisting to Toronto Stock Exchange

August 21, 2025

Pinnacle Silver and Gold

August 21, 2025

Morocco, Emmerson Advance Toward US$2.2 Billion Arbitration Over Halted Potash Project

August 21, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (300)
- Investing (1,258)
- Science (10)
- World News (1,120)

Disclaimer: investmentintelligencesphere.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 investmentintelligencesphere.com | All Rights Reserved

Top

Business
World News
Investing
Science

Type above and press Enter to search. Press Esc to cancel.